Q2 2026 M&A Update
As part of our quarterly pharmaceutical industry review, we are pleased to share an update on merger and acquisition activity to help our clients understand the market dynamics impacting pharmaceutical…
Q1 2026 M&A Update
As part of our quarterly pharmaceutical industry review, we are pleased to share an update on merger and acquisition activity to help our clients understand the market dynamics impacting pharmaceutical…
Q2 2025 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…
Q4 2024 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…
Q3 2024 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…
Q2 2024 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…